| TDD rate exposed | TDD rate non-exposed |  |  |  | ||||
---|---|---|---|---|---|---|---|---|---|
Clinical factor | N | Person yearsa | Rate (%) | N | Person years | Rate (%) | HR adjusted (95% CI) | HR unadjusted (95% CI) | Sensitivity analyses (HR adjusted) 95% CI)b |
Sexual dysfunction | 44 | 505 | 8.7 | 84 | 2637 | 3.2 | 2.68 (1.72, 4.16)* | 2.72 (2.20, 3.37)* | 2.61 (1.56, 4.39)* |
Amenorrhea | 11 | 126 | 8.7 | 107 | 2810 | 3.8 | 2.54 (2.10, 3.09)* | 2.38 (1.74, 3.26)* | 2.48 (1.83, 3.36)* |
Extra-pyramidal symptoms | 89 | 273 | 32.6 | 40 | 2875 | 1.4 | 13.94 (6.90, 28.19)* | 17.20 (9.11, 32.47)* | 17.79 (6.70, 47.26)* |
FGA use vs no AP | 31 | 287 | 10.8 | 9 | 768 | 1.2 | 2.64 (1.94, 3.60)* | 2.64 (1.97, 3.53)* | 2.32 (1.66, 3.24)* |
SGA use vs no AP | 69 | 1902 | 3.6 | 9 | 768 | 1.2 | 2.18 (1.20, 3.97)†| 2.16 (1.02, 4.54)†| 1.50 (0.79, 2.85) |